Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Saroja Pharma Ind
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 27.98 % | 25.68 % |
|
5yr average Equity Multiplier
|
1.23 | 4.23 | -1.27 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 2.66 | 0.6 |
|
5yr Avg Net Profit Margin
|
77.44 % | 2.05 % | -27.67 % |
|
Price to Book
|
1.6 | 0.0 | 0.0 |
|
P/E
|
29.58 | 12.96 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
63.13 Days | 72.5 Days | 113.0 Days |
|
Inventory Days
|
54.75 Days | 9.36 Days | 182.62 Days |
|
Days Receivable
|
11.98 Days | 145.45 Days | 77.44 Days |
|
Days Payable
|
169.78 Days | 53.02 Days | 195.35 Days |
|
5yr Average Interest Coverage Ratio
|
820.35 | 2.62 | -1.07 |
|
5yr Avg ROCE
|
17.27 % | 33.47 % | -18.91 % |
|
5yr Avg Operating Profit Margin
|
-130.11 % | 4.85 % | -2.35 % |
|
5 yr average Debt to Equity
|
0.0 | 1.55 | -1.84 |
|
5yr CAGR Net Profit
|
-26.08 % | 7.13 % | -24.21 % |
|
5yr Average Return on Assets
|
8.75 % | 5.43 % | -17.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 73.02 % | 34.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.45 % | 0.0 | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Saroja Pharma Ind
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|